Enhancing Beta Cell Replacement Therapies: Exploring Calcineurin Inhibitor-Sparing Immunosuppressive Regimens

被引：1
|
作者：
Caldara, Rossana [1 ]
Tomajer, Valentina [2 ]
Piemonti, Lorenzo [3 ,4 ]
机构：
[1] IRCCS Osped San Raffaele, Regenerat & Transplant Med Unit, Milan, Italy
[2] IRCCS Osped San Raffaele, Pancreas Translat & Clin Res Ctr, Pancreat Surg, Milan, Italy
[3] IRCCS Osped San Raffaele, Diabet Res Inst, Milan, Italy
[4] Univ Vita Salute San Raffaele, Milan, Italy
来源：
TRANSPLANT INTERNATIONAL | 2023年 / 36卷
关键词：
islet transplant; immunosuppression; calcineurin inhibitors; calcineurin inhibitor toxicity; tolerance induction; ISLET TRANSPLANTATION; INSULIN INDEPENDENCE; PHASE-3; TRIAL;
D O I：
10.3389/ti.2023.11565
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] IS MYCOPHENOLATE MOFETIL (MMF) REQUIRED IN RENAL SPARING DELAYED CALCINEURIN INHIBITOR (CI) REGIMENS IN LIVER TRANSPLANTATION (LTX)?
    Patel, Neha
    Taber, David J.
    Weimert, Nicole A.
    Dunn, Brianna L.
    Scheffert, Jenna L.
    Hughes, Michael G.
    McGillicuddy, John W.
    Bratton, Charles F.
    Lin, Angello
    Chavin, Kenneth D.
    Baliga, Prabhaker K.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S187 - S188
  • [42] Promises and pitfalls of beta cell-replacement therapies
    Kolic, Jelena
    Johnson, James D.
    NATURE METABOLISM, 2021, 3 (08) : 1036 - 1037
  • [43] Exploring Immunoconditioning Regimens for Cell Therapies in Murine Models for Toxicology Studies
    Li, C.
    Bujold, K.
    Ballesteros, C.
    Downey, A-M.
    Wong, K.
    Authier, S.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2021, 40 (01) : 71 - 72
  • [44] Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1
    Lennox, Jeffrey L.
    Landovitz, Raphael J.
    Ribaudo, Heather J.
    Ofotokun, Ighovwerha
    Na, Lumine H.
    Godfrey, Catherine
    Kuritzkes, Daniel R.
    Sagar, Manish
    Brown, Todd T.
    Cohn, Susan E.
    McComsey, Grace A.
    Aweeka, Francesca
    Fichtenbaum, Carl J.
    Presti, Rachel M.
    Koletar, Susan L.
    Haas, David W.
    Patterson, Kristine B.
    Benson, Constance A.
    Baugh, Bryan P.
    Leavitt, Randi Y.
    Rooney, James F.
    Seekins, Daniel
    Currier, Judith S.
    ANNALS OF INTERNAL MEDICINE, 2014, 161 (07) : 461 - +
  • [45] Cost Comparison of Immunosuppressive Regimens: Belatacept vs. a Calcineurin Inhibitor Regimen in the First Year Post-Kidney Transplant
    Toledo, A. H.
    Deyo, J. C.
    Deshmukh, N. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 522 - 522
  • [46] Everolimus-based calcineurin-inhibitor sparing regimens for kidney transplant recipients: a systematic review and meta-analysis
    Su, Liya
    Tam, Ngalei
    Deng, Ronghai
    Chen, Philip
    Li, Haibo
    Wu, Linwei
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (10) : 2035 - 2044
  • [47] Islet Transplantation & beta-Cell Replacement Therapies for Diabetes
    Berney, Thierry
    Korsgren, Olle
    Posselt, Andrew
    Pileggi, Antonello
    JOURNAL OF TRANSPLANTATION, 2011, 2011
  • [48] Everolimus-based calcineurin-inhibitor sparing regimens for kidney transplant recipients: a systematic review and meta-analysis
    Liya Su
    Ngalei Tam
    Ronghai Deng
    Philip Chen
    Haibo Li
    Linwei Wu
    International Urology and Nephrology, 2014, 46 : 2035 - 2044
  • [49] Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation?
    Zeier, Martin
    van der Giet, Markus
    TRANSPLANT INTERNATIONAL, 2011, 24 (01) : 30 - 42
  • [50] A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function
    Chang, GJ
    Mahanty, HD
    Vincenti, F
    Freise, CE
    Roberts, JP
    Ascher, NL
    Stock, PG
    Hirose, R
    CLINICAL TRANSPLANTATION, 2000, 14 (06) : 550 - 554
12345